Brussels - June 24, 2013 - Christopher A. Viehbacher, Chief Executive Officer of Sanofi, was elected today President of EFPIA, the European Federation of Pharmaceutical Industries and Associations, for a 2-year term.
Stepping into his role as the new President of EFPIA, Mr. Viehbacher called on the European Union, member states and industry to work together in facing Europe’s economic and social challenges. He emphasised the pharmaceutical industry’s potential to help revive Europe’s economy while improving the quality of life for its people, and outlined EFPIA’s priorities for the industry.
In 2012 alone, the R&D-based pharmaceutical industry in Europe generated 700,000 jobs, and created a positive trade balance of an estimated € 80 billion. This industry is driven by innovation, by science, and, most importantly, by the health needs of people.
“I look forward to working with my EPFIA colleagues and with others across the health system to advance policies that recognize the strategic importance of our industry in terms of better health for patients and economic growth,” Mr. Viehbacher concluded.
Joining Mr. Viehbacher at the head of the EFPIA board will be two newly elected Vice Presidents, Dr. Roch Doliveux, Chief Executive Officer of UCB, and Mr. Joseph Jimenez, Chief Executive Officer of Novartis.
(photo credits : Lander Loeckx)